BCL2L1 and colorectal carcinoma: In summary, we are the first to discover that Cyr61 levels are significantly upregulated in L-OHP-resistant CRC cells and that high Cyr61 expression can effectively protect CRC cells from L-OHP-induced apoptosis by increasing Bcl-xL, leading to failure of CRC cells to respond to L-OHP chemotherapy.